Acta Cytol

1. LONGATTO-FILHO A, Schmitt FC
   Ongoing Challenges in Maintaining the Diagnostic Quality of Cervical Cytopathology: Is It Possible to Minimize Differences in Morphological Interpretations?
   Acta Cytol. 2026;70:40-45.
   

   >> Share

   
   
2. EDVARDSSON H, Dillner J
   Human Papillomavirus Primary Screening and Collaboration in Quality Assurance Work between Laboratories.
   Acta Cytol. 2026;70:46-51.
   

   >> Share

   
   
3. KHOLOVA I
   Not Enough Cells: How Insufficient Cytological Specimens Are Mirrored by Reporting Systems - Journey from the Bethesda to the WHO Reporting Systems.
   Acta Cytol. 2026;70:72-83.
   

   >> Share

   
   
4. HARINATH L, Bai X, Minkowitz J, Zeng X, et al
   Artificial Intelligence in Gynecologic Cytology.
   Acta Cytol. 2026;70:52-71.
   

   >> Share

   
   

   
   Afr J Prim Health Care Fam Med

5. POLANE MG, Dlamini SB
   A qualitative study exploring the primary health care nurses' lived experiences of cervical cancer screening.
   Afr J Prim Health Care Fam Med. 2026;18:e1-e9.
   

   >> Share

   
   

   
   Anal Chem

6. PANG S, Jian X, Wei W, Chen Y, et al
   Phosphoproteins Identification on Stretchable Photonic Crystal for Cervical Cancer Assessment.
   Anal Chem. 2026 Feb 6. doi: 10.1021/acs.analchem.5c05791.
   

   >> Share

   
   

   
   Ann Intern Med

7. WENTZENSEN N, Egemen D
   Adapting Cervical Cancer Screening in Vaccinated Populations: Individualized Versus Population-Based Approaches.
   Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-05559.
   

   >> Share

   
   
8. 
   Summary for Patients: Optimizing Cervical Cancer Screening by Age at Vaccination for Human Papillomavirus.
   Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-03192.
   

   >> Share

   
   
9. PEDERSEN K, Di Silvestre J, Sy S, Portnoy A, et al
   Optimizing Cervical Cancer Screening by Age at Vaccination for Human Papillomavirus: Health and Resource Implications.
   Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-03192.
   

   >> Share

   
   

   
   Ann Surg Oncol

10. WANG Q, Su M, Zheng Y
    The Application of Tumor-Free Technique in Robotic Single-Site Radical Hysterectomy for Early Stage Cervical Cancer.
    Ann Surg Oncol. 2026 Feb 5. doi: 10.1245/s10434-025-19026.
    

    >> Share

    
    

    
    Anticancer Res

11. SAGER G, Livik M, Hellevik T, Orbo A, et al
    Extracellular cGMP Levels Predict the Response of C4-1 Cervical Cancer Cells to Ionizing Radiation.
    Anticancer Res. 2026;46:611-618.
    

    >> Share

    
    

    
    Aust N Z J Obstet Gynaecol

12. ALLIN T, Taunton C, Ketchell F, Hempenstall A, et al
    High Cervical Cancer Screening Rates and Low Human Papillomavirus Detection in the Remote Torres Strait, Far North Queensland.
    Aust N Z J Obstet Gynaecol. 2026;66:e70060.
    

    >> Share

    
    
13. TRAN CT, Wang M, Plymoth M, Chen J, et al
    Accuracy of Self-Reported Cervical Screening Status Among Pregnant Women.
    Aust N Z J Obstet Gynaecol. 2025 Nov 26. doi: 10.1111/ajo.70057.
    

    >> Share

    
    

    
    BMC Cancer

14. FEI C, Chen W, Liu J, Wang J, et al
    A real-world multicenter study on opportunistic cervical cancer screening in hospital in China: comparison of TruScreen device, cytology, and HPV testing for detecting high-grade cervical lesions.
    BMC Cancer. 2026 Feb 4. doi: 10.1186/s12885-026-15590.
    

    >> Share

    
    

    
    BMC Infect Dis

15. SHI L, Gao X, Huang L, Gao Z, et al
    Efficacy, safety and immunogenicity of a recombinant human papillomavirus bivalent (types 16, 18) vaccine in healthy 18-30-year-old Chinese women: a phase III, double-blind, randomized, controlled trial.
    BMC Infect Dis. 2025;26:248.
    

    >> Share

    
    

    
    BMC Med

16. YI H, Huang J, Zhang N, Sundquist J, et al
    The association of post-conization pregnancy with subsequent cervical lesions: evidence from a nationwide cohort in Sweden.
    BMC Med. 2025;24:61.
    

    >> Share

    
    

    
    BMC Med Imaging

17. JIANG N, Xin Z, Zhang Y, Liu Y, et al
    Clinical translation of a DWI-radiomics nomogram integrating serum biomarkers for pretreatment staging of cervical cancer.
    BMC Med Imaging. 2026 Jan 30. doi: 10.1186/s12880-026-02175.
    

    >> Share

    
    

    
    BMC Public Health

18. SHAHRY P, Mohammadi Khoshoei Z, Cheraghi M, Talaiezadeh A, et al
    Population-based epidemiological study of cervical cancer in Khuzestan province, Iran (2014-2019).
    BMC Public Health. 2026 Jan 31. doi: 10.1186/s12889-026-26428.
    

    >> Share

    
    

    
    BMC Womens Health

19. AYSI?N N, Kurt Can E, Koltas S, Yilmaz M, et al
    A qualitative study on the experiences of stigmatisation and spiritual coping among women diagnosed with cervical cancer in Turkey.
    BMC Womens Health. 2026 Feb 2. doi: 10.1186/s12905-026-04318.
    

    >> Share

    
    
20. AHADI L, Zarei F, Kazemnejad A
    From screen to screening: a randomized controlled trial on mHealth vs. traditional training on knowledge, attitudes, practice, self-efficacy, and adherence intention to pap smear.
    BMC Womens Health. 2025;26:61.
    

    >> Share

    
    

    
    BMJ

21. TIAN X, Cao C, Wang L, Zhang J, et al
    Testing menstrual blood for human papillomavirus during cervical cancer screening in China: cross sectional population based study.
    BMJ. 2026;392:e084831.
    

    >> Share

    
    
22. WISE J
    Cervical cancer: Fewer screening tests needed, study suggests.
    BMJ. 2026;392:s224.
    

    >> Share

    
    

    
    BMJ Open

23. NIRMALKAR AP, Mamulwar M, Godbole S, Shahabuddin SM, et al
    Cost-effectiveness of cervical cancer screening among women living with HIV in India: study protocol.
    BMJ Open. 2026;16:e108752.
    

    >> Share

    
    

    
    Bull Cancer

24. CHARGARI C, Martinez A, Michels J, Lecuru F, et al
    [French recommendations for clinical practice, Nice-Saint-Paul-de-Vence 2024-2025: Management of localized cervical cancer].
    Bull Cancer. 2026 Jan 29:S0007-4551(26)00025.
    

    >> Share

    
    
25. SABATIER R, Hennequin C, Martin-Babau J, Follana P, et al
    [French recommendations for clinical practice, Nice-Saint-Paul de Vence 2024-2025: Management of advanced cervical cancer].
    Bull Cancer. 2026 Jan 30:S0007-4551(26)00022.
    

    >> Share

    
    

    
    Cancer

26. TAMRAKAR VK, Sharma K, Singh P, Bhargava A, et al
    Cervical cancer elimination in India: Repurposing diagnostics, vaccination, and accelerating policy for the 2030 target.
    Cancer. 2026;132:e70292.
    

    >> Share

    
    

    
    Cancer Causes Control

27. AGYEMAN AA, Bader G, Opoku NKO
    The impact of human papillomavirus vaccination implementation in reducing cervical cancer in a heterosexual population.
    Cancer Causes Control. 2026;37:42.
    

    >> Share

    
    
28. LOOS G, Duclos M, Ennequin G
    Physical activity and exercise in cervical cancer: a state-of-the-art review.
    Cancer Causes Control. 2026;37:41.
    

    >> Share

    
    

    
    Cancer Epidemiol Biomarkers Prev

29. CONTRERAS GARDUNO S, Saraiba-Rabanales V, Chavarri-Guerra Y, Soto-Perez-de-Celis E, et al
    Trends in Cervical Cytology Test Reports and Cervical Dysplasia Severity according to Social Deprivation in Mexico (2013-2019): An Analysis of a National Database.
    Cancer Epidemiol Biomarkers Prev. 2026;35:341-347.
    

    >> Share

    
    

    
    Cancer Lett

30. RUAN J, Gao C, Wang R, Hu B, et al
    A novel dual-effect bimodal chip cancer research platform: Chips system interconnected vascularized tumor organoids culture with real-time exploration and detection from bench to bedside.
    Cancer Lett. 2026;640:218110.
    

    >> Share

    
    

    
    Cardiology

31. HULLON D, Kara Damor D, Singh T, ALKhatib M, et al
    The Overlay of Cervical Cancer with Cardiac Metastasis.
    Cardiology. 2026 Feb 2:1-22. doi: 10.1159/000550823.
    

    >> Share

    
    

    
    Clin Nucl Med

32. YANG L, Zou Y, Tian R
    Cervical Paraganglioma Negative on Both 68Ga-DOTATATE and 18F-FDG PET/CT Studies.
    Clin Nucl Med. 2025 Apr 24. doi: 10.1097/RLU.0000000000005895.
    

    >> Share

    
    

    
    Crit Rev Oncol Hematol

33. PARIDA P, Mehta A, Raj EA, Guruvare S, et al
    Diagnostic and prognostic significance of circulating HPV cfDNA in cervical cancer: A systematic review and meta-analysis.
    Crit Rev Oncol Hematol. 2026;220:105161.
    

    >> Share

    
    

    
    Curr Issues Mol Biol

34. VIDALINA D, Ghali L, Kassouf N, Li S, et al
    The Therapeutic Effect of EZH2 Inhibitors in Targeting Human Papillomavirus Associated Cervical Cancer.
    Curr Issues Mol Biol. 2025;47:990.
    

    >> Share

    
    
35. LEI X, Yang W, Xu S, Wu H, et al
    Regulation of Energy Metabolism and Lipid Metabolites by IMP3 in Cervical Cancer.
    Curr Issues Mol Biol. 2025;47:1014.
    

    >> Share

    
    
36. ZHOU Z, Li J, Zhao X, Xu H, et al
    Gramine Suppresses Cervical Cancer by Targeting CDK2: Integrated Omics-Pharmacology and In Vitro Evidence.
    Curr Issues Mol Biol. 2026;48:64.
    

    >> Share

    
    

    
    Cytotechnology

37. ZHANG J, Shen J, Yuan L
    Effect of HOXB7 in promoting proliferation, invasion and migration of cervical cancer cells.
    Cytotechnology. 2026;78:38.
    

    >> Share

    
    

    
    Diagn Cytopathol

38. OZDEMIR CY, Marangoz B, Ozdemir N, Cicekli N, et al
    Clinical Outcomes and Risk Implications of HPV 31 Infection: A 10-Year Retrospective Cohort Study.
    Diagn Cytopathol. 2026;54:167-172.
    

    >> Share

    
    
39. HARINATH L, Matsko J, Colaizzi A, Elishaev E, et al
    Morphologic Evaluation of Hyperchromatic Crowded Groups Present in Cervical Thin Prep Cytology Tests as Identified by the Hologic Genius Digital Diagnostics System: A Descriptive Study.
    Diagn Cytopathol. 2026;54:173-183.
    

    >> Share

    
    

    
    Dtsch Arztebl Int

40. SCHWAB R, Emrich K, Heimes AS, Schwarzer K, et al
    Combined Cervical Cancer Screening and the Incidence of Adenocarcinoma: An Analysis of Data From the German Cancer Registries.
    Dtsch Arztebl Int. 2026;.
    

    >> Share

    
    

    
    Front Cell Infect Microbiol

41. PENG L, Yu S, Dong Y, Gu H, et al
    A potential association between the characteristics of the multi-organ microbiota and lymph node metastasis in cervical cancer.
    Front Cell Infect Microbiol. 2026;15:1639811.
    

    >> Share

    
    

    
    Front Genet

42. SHEN Y, Kang M
    Retrospective analysis of preoperative serum tumor marker levels and their correlation with pathological characteristics and prognosis in cervical cancer patients.
    Front Genet. 2026;17:1724789.
    

    >> Share

    
    

    
    Front Oncol

43. ZHANG Y, Yuan J, Chen L
    Transforming cervical cancer pathological diagnosis through artificial intelligence: progress, performance, and barriers to clinical implementation.
    Front Oncol. 2026;15:1716018.
    

    >> Share

    
    

    
    Front Public Health

44. SHEN X, Guo W, Yao C, Wu H, et al
    Epidemiological analysis of human papillomavirus and its subtype infections in 36,248 women in Wuhan, China.
    Front Public Health. 2026;14:1745604.
    

    >> Share

    
    

    
    Gynecol Oncol Rep

45. ROTHSCHILD H, Keverline K, McKinney S, Farrell M, et al
    From #cervicalcancerscreening to #LEEP - Quality and accuracy of cervical cancer content on TikTok.
    Gynecol Oncol Rep. 2025;63:102018.
    

    >> Share

    
    

    
    Health Expect

46. NEWHOUSE R, McWilliams L, Baker-Rand H, Cullimore V, et al
    Investigating the Acceptability of Cervical Screening and Self-Sampling in Postnatal Women at the 6-Week Postnatal Check-Up: A Qualitative Study.
    Health Expect. 2026;29:e70582.
    

    >> Share

    
    

    
    Health Psychol Rev

47. DOU J, Liu Z
    Mapping interventions to increase uptake of breast and cervical cancer screening along the Intervention Ladder: a systematic review.
    Health Psychol Rev. 2026 Feb 4:1-30. doi: 10.1080/17437199.2026.2623887.
    

    >> Share

    
    

    
    Hum Vaccin Immunother

48. RAJAIE S, Emamgholipour S, Azari S, Karimi Z, et al
    Acceptance and the willingness to pay for human papilloma virus (HPV) vaccine: A systematic review.
    Hum Vaccin Immunother. 2026;22:2609345.
    

    >> Share

    
    
49. MABROUK NOUH F, Abualruz H, Al-Zoubi M, Al-Mugheed K, et al
    Nursing students' knowledge and attitudes toward human papillomavirus vaccination and infection.
    Hum Vaccin Immunother. 2026;22:2609329.
    

    >> Share

    
    

    
    Indian J Med Res

50. JOSTEN K, Rose Dhar R, Reshmi B, Natti Krishna V, et al
    Barriers to HPV vaccination among adolescent girls in India: A scoping review.
    Indian J Med Res. 2026;162:743-753.
    

    >> Share

    
    

    
    Indian J Public Health

51. HARIPRASAD R, Bhatnagar T
    A Systematic Framework for Evaluating Cervical Cancer Screening Programs: Innovative Approaches and Best Practices.
    Indian J Public Health. 2026;70.
    

    >> Share

    
    

    
    Infect Disord Drug Targets

52. GUIDOBALDI L, Cafiero C, Stillitano G, Ricciardi E, et al
    Cervical Cancer Complexity: Exploring the Coexistence of CIN3 and Glandular Lesions.
    Infect Disord Drug Targets. 2026.
    

    >> Share

    
    

    
    Int Immunopharmacol

53. GHOLAMI S, Aghbash PS, Ravanlo ZZ, Rahimi SB, et al
    Therapeutic targeting of the HPV E7 oncoprotein: Current advances and emerging strategies.
    Int Immunopharmacol. 2026;172:116193.
    

    >> Share

    
    

    
    Int J Cancer

54. RASMUSSEN RMW, Munk C, Kjaer SK
    Is the beneficial effect of multi-cohort HPV vaccination on cervical cancer and precancerous lesions seen across all educational levels?
    Int J Cancer. 2026 Feb 6. doi: 10.1002/ijc.70360.
    

    >> Share

    
    

    
    Int J Clin Oncol

55. KAIDO Y, Kagabu M, Chiba Y, Sato S, et al
    Safety and oncologic outcomes of total laparoscopic versus abdominal hysterectomy following diagnostic conization for adenocarcinoma in situ and stage IA1 cervical cancer: a multicenter retrospective study.
    Int J Clin Oncol. 2026 Jan 30. doi: 10.1007/s10147-026-02971.
    

    >> Share

    
    

    
    Int J Gynecol Cancer

56. SARDINHA TG, Vale DB, Discacciati MG, Triglia RM, et al
    Diagnostic performance and clinical utility of p16 immunostaining in a population-based HPV DNA screening program.
    Int J Gynecol Cancer. 2026;36:104451.
    

    >> Share

    
    
57. ELMEHRATH AO, Njala B, Sakala D, Nogueras-Gonzalez GM, et al
    Demographic and social determinants of human immunodeficiency virus status among women with cervical cancer in a low-resource setting.
    Int J Gynecol Cancer. 2025 Dec 26:102867. doi: 10.1016/j.ijgc.2025.102867.
    

    >> Share

    
    
58. HEMIDA R, Barakat R, Nabil H, Hasan M, et al
    Retraction notice to "Cervical cancer elimination in low-resource countries: low-cost strategy" [International Journal of Gynecological Cancer, Volume 35 Issue 9 (2025) 101828].
    Int J Gynecol Cancer. 2026;36:104540.
    

    >> Share

    
    
59. YONEMORI K, Nishio S, Suzuki S, Hasegawa K, et al
    Tisotumab vedotin in Japanese patients with recurrent or metastatic cervical cancer: results from the innovaTV 301/ENGOT-cx12/GOG-3057 trial.
    Int J Gynecol Cancer. 2025 Dec 31:104450. doi: 10.1016/j.ijgc.2025.104450.
    

    >> Share

    
    
60. CIANCIA M, Moro F, Mascilini F, Testa AC, et al
    Response to the Correspondence by Peng et al. on "Diagnostic performance of ultrasound-guided biopsy for detecting recurrent or persistent cervical cancer after chemoradiotherapy: a prospective, single-center study" by Mascilini et al.
    Int J Gynecol Cancer. 2026 Jan 18:104499. doi: 10.1016/j.ijgc.2026.104499.
    

    >> Share

    
    
61. O'SHEA J, Yu K, Chang D, Khaw P, et al
    Survival and patterns of failure in small cell neuroendocrine carcinoma of the cervix treated with definitive chemoradiotherapy.
    Int J Gynecol Cancer. 2026;36:102874.
    

    >> Share

    
    
62. SEO JH, Chung YE, Lim S, Kim SY, et al
    Pre-diagnostic physical activity and mortality in cervical cancer: a nationwide cohort study.
    Int J Gynecol Cancer. 2026 Jan 16:104477. doi: 10.1016/j.ijgc.2026.104477.
    

    >> Share

    
    
63. KOBAYASHI M, Yao JA, Lee MW, Nakagawa S, et al
    Relative survival of large cell to small cell neuroendocrine carcinoma of the uterine cervix.
    Int J Gynecol Cancer. 2026;36:102852.
    

    >> Share

    
    

    
    Int J Prev Med

64. TJALMA WA
    Rare Today, Common Tomorrow: Strengthening Cervical Cancer Prevention in Low-Incidence Countries is Urgently Needed.
    Int J Prev Med. 2025;16:85.
    

    >> Share

    
    

    
    iScience

65. WANG X, Wang Q, Ding G, Wang J, et al
    Artificial intelligence for colposcopic and cytological image analysis in early cervical cancer detection.
    iScience. 2026;29:114627.
    

    >> Share

    
    

    
    J Biochem Mol Toxicol

66. KAYA M, Kara Y, Sanli-Mohamed G
    Anticancer Properties of Newly Synthesized Pyrrole Derivatives as Potential Tyrosine Kinase Inhibitors.
    J Biochem Mol Toxicol. 2026;40:e70665.
    

    >> Share

    
    

    
    J Cancer Policy

67. ADANKWAH E, Mensah ABB, Konney T, Nones M, et al
    A pilot study on the acceptability and feasibility of HPV self-sampling for cervical cancer screening among women attending urban hospitals in Kumasi, Ghana.
    J Cancer Policy. 2026 Jan 30:100710. doi: 10.1016/j.jcpo.2026.100710.
    

    >> Share

    
    

    
    J Clin Ultrasound

68. WANG Z, Luo H
    Diagnostic Value of Ultrasound in Primary Cervical Ewing's Sarcoma: Two Case Reports and Literature Review.
    J Clin Ultrasound. 2026;54:490-498.
    

    >> Share

    
    

    
    J Ethnopharmacol

69. CHEN J, Wu M, Zhang R, Cao Y, et al
    Luteolin, a Bioactive Compound from Celastrus orbiculatus Stem, Inhibits Cervical Cancer via CA2 Suppression: A Translational Study Bridging Basic Research and Clinical Application.
    J Ethnopharmacol. 2026 Feb 4:121326. doi: 10.1016/j.jep.2026.121326.
    

    >> Share

    
    

    
    J Obstet Gynaecol

70. XIA W, Wang J, Yang X, Sha Y, et al
    DNA methylation triage of human papillomavirus-positive atypical squamous cells of undetermined significance in cervical cancer screening.
    J Obstet Gynaecol. 2026;46:2623828.
    

    >> Share

    
    

    
    J Public Health Afr

71. CHEPKORIR J, Kivuti-Bitok L, Perrin N, Gross D, et al
    Cervical cancer information access and dissemination strategies among rural Kenyan women: A mixed methods study.
    J Public Health Afr. 2026;17:1457.
    

    >> Share

    
    

    
    JAMA Health Forum

72. ZHANG L, Zhang S, Liu S, Jian W, et al
    Human Papillomavirus Vaccination Policies and Discourse on Social Media.
    JAMA Health Forum. 2026;7:e256425.
    

    >> Share

    
    

    
    JAMA Netw Open

73. FOKOM DOMGUE J, Chandra M, Oladoyin O, Desai M, et al
    Women's Preferences for Home-Based Self-Sampling or Clinic-Based Testing for Cervical Cancer Screening.
    JAMA Netw Open. 2026;9:e2558841.
    

    >> Share

    
    

    
    Lakartidningen

74. MILERAD H, Bonander C, Nordqvist Kleppe S, Dillner J, et al
    [Geomapping of 10-year coverage rate of cervical cancer screening in Sweden - a basis for targeting population-level interventions to improve screening].
    Lakartidningen. 2026;123:25052.
    

    >> Share

    
    

    
    Lancet HIV

75. DALAL S, Sundstrom K, Silva R, Taghavi K, et al
    Age-specific distribution of cervical precancer and cancer among women living with HIV across seven countries: a systematic review and an individual patient data meta-analysis.
    Lancet HIV. 2026;13:e126-e137.
    

    >> Share

    
    

    
    Lancet Public Health

76. SMITH MA, Killen J, Jamieson L, O'Farrell X, et al
    Accelerating cervical cancer elimination in Aboriginal and Torres Strait Islander women: a modelling study.
    Lancet Public Health. 2026 Feb 3:S2468-2667(26)00005.
    

    >> Share

    
    

    
    Mamm Genome

77. LU X, Yao L, Xu X, Rexiti MG, et al
    m5c-modified LINC01094 participates in epithelial-mesenchymal transition and metastasis of cervical cancer cells via the ZNF582-SIRT1/p53 axis.
    Mamm Genome. 2026;37:32.
    

    >> Share

    
    

    
    Med Oncol

78. YANG J, Shi Z, Song T, Shao Y, et al
    LncRNA TMPO-AS1 aggravates the cisplatin resistance in cervical cancer via miR-140-5p/DNMT1 axis-mediated DNA methylation of KLK10.
    Med Oncol. 2026;43:136.
    

    >> Share

    
    

    
    Med Phys

79. PENG Z, Liu C, Tang D, Li S, et al
    Slice-prompted HR-CTV interactive segmentation for cervical cancer brachytherapy: A multi-center study.
    Med Phys. 2026;53:e70305.
    

    >> Share

    
    

    
    medRxiv

80. LOU H, Langan D, Syracuse N, Murphy EA, et al
    A Three-subtype Molecular model of Cervical Cancer: Multiple PI3K Pathway inhibitors suppress growth and cooperate with HPV-directed immunotherapy.
    medRxiv [Preprint]. 2026 Jan 23:2026.01.21.26344562.
    

    >> Share

    
    

    
    Microbiol Spectr

81. WANG Z, Hu T, Liu W, Zhou H, et al
    Development and clinical validation of an ERA-CRISPR/Cas12a assay for the rapid detection of 14 high-risk HPV types.
    Microbiol Spectr. 2026;14:e0303625.
    

    >> Share

    
    

    
    Obstet Gynecol Int

82. BAHARDOUST M, Ghalavand N, Shamohammadi M, Asl MS, et al
    Pretreatment CRP-Albumin-Lymphocyte (CALLY) Index as a Prognostic Biomarker of Survival and Recurrence-Free Survival in Patients With Early-Stage Cervical Cancer After Radical Hysterectomy: A Multicenter Retrospective Cohort Study.
    Obstet Gynecol Int. 2026;2026:6137796.
    

    >> Share

    
    
83. WANG R, Liu S, Wang R, Guo Q, et al
    Different Expressions and Methylation Patterns of cGAS and STING in Cervical Cancer.
    Obstet Gynecol Int. 2026;2026:2210380.
    

    >> Share

    
    

    
    Oncol Lett

84. OZGURLUK I, Erdem HB, Alay MT, Oktar O, et al
    Unveiling mitochondrial DNA copy number alterations: Insights into progression from cervical intraepithelial neoplasia to cervical cancer.
    Oncol Lett. 2026;31:117.
    

    >> Share

    
    

    
    Pan Afr Med J

85. ZRAIDI M, Kamel N, El Belloute G, Abidi K, et al
    [Obstetrical characteristics related to cervical cancer in the Northern Territory of the Rabat-Sale-Kenitra Region, Morocco].
    Pan Afr Med J. 2025;52:102.
    

    >> Share

    
    
86. ZHANG F, Hu J, Bian J, Lan Y, et al
    Mullerian adenosarcoma mimicking cervical carcinoma in a 79-year-old woman: diagnostic challenges and laparoscopic treatment: a case report.
    Pan Afr Med J. 2025;52:110.
    

    >> Share

    
    

    
    Photodiagnosis Photodyn Ther

87. ZHANG Z, Kong D, Ding Y, Lu M, et al
    Laser ablation combined with photodynamic therapy for complex vaginal HSIL after repeat cervical conizations: a case report.
    Photodiagnosis Photodyn Ther. 2026;57:105267.
    

    >> Share

    
    

    
    Phys Imaging Radiat Oncol

88. NING B, Li Z, Yu D, Li C, et al
    Deep learning and dual-radiomics model incorporating brachytherapy applicator type to predict radiation-induced acute rectal injury in cervical cancer patients.
    Phys Imaging Radiat Oncol. 2026;37:100908.
    

    >> Share

    
    

    
    Radiother Oncol

89. SPAMPINATO S, Kutluyer S, Almaz S, Schuur N, et al
    Impact of primary radiotherapy on the psychosocial well-being of patients with locally advanced cervical cancer (IMPRaCC study).
    Radiother Oncol. 2026 Jan 30:111405. doi: 10.1016/j.radonc.2026.111405.
    

    >> Share

    
    

    
    Res Sq

90. RODRIGUEZ NM, Case X, Balian L, Ziolkowski R, et al
    Cervical Cancer Screening Rates and Associated Sociodemographic and Behavioral Factors among People Experiencing Homelessness in Indiana.
    Res Sq [Preprint]. 2026 Jan 30:rs.3.rs-8524257. doi: 10.21203/rs.3.rs-8524257.
    

    >> Share

    
    

    
    Retrovirology

91. JAHANSHAHI S, Soleimani-Jelodar R, Jalilvand S, Shoja Z, et al
    Investigation of the expression level of human endogenous retrovirus E env transcript in cervical cancer.
    Retrovirology. 2026 Feb 2. doi: 10.1186/s12977-025-00672.
    

    >> Share

    
    

    
    Sci Rep

92. TATARNIKOVA I, Talyshev V, Sen'kova A, Markov O, et al
    Two paired HPV-59 cervical cancer cell lines with distinct chemoradioresistant phenotypes.
    Sci Rep. 2026 Feb 4. doi: 10.1038/s41598-026-36260.
    

    >> Share

    
    
93. LEINO A, Numminen E, Kares S, Merio M, et al
    Clinical relevance of partial HPV genotyping in cervical cancer screening.
    Sci Rep. 2026 Feb 4. doi: 10.1038/s41598-026-36594.
    

    >> Share

    
    
94. XIE X, Liu C, Liu X, Hou L, et al
    Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Sci Rep. 2026;16:5155.
    

    >> Share

    
    

    
    Taiwan J Obstet Gynecol

95. IMATAKE H, Taki M, Yamanoi K, Murakami R, et al
    Healthcare provider bias in cancer treatment decisions for elderly patients.
    Taiwan J Obstet Gynecol. 2026;65:29-33.
    

    >> Share

    
    
96. YANG ST, Chang CW, Wang PH
    Clinical impact of glandular involvement in high-grade squamous intraepithelial lesions of the cervix.
    Taiwan J Obstet Gynecol. 2026;65:64-69.
    

    >> Share

    
    

    
    Vaccine

97. COBLENTZ EG, Packee CR, Ky SL, Brubaker AG, et al
    Prioritization of HPV vaccine preventable diseases among emerging adults - Implications for health education and communication.
    Vaccine. 2026;74:128223.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share